In terms of its effect on cancer progression and development, decreased expression of PDHA1 was verified to be associated with an unfavorable outcome in a variety of types of cancers including ovarian (51), liver (52) and esophageal cancer (53). The gene discussed is PDHA1; the disease is esophageal cancer.